Our company has officially signed a contract to settle in Jimei District, Xiamen City, to create a new benchmark for growth oriented enterprises through government enterprise collaboration

        Recently, Xiamen HORN Pharmaceutical Co., Ltd. (hereinafter referred to as "our company") officially signed a growth oriented enterprise cooperation agreement with Xiamen Jimei District Investment Promotion Bureau. According to the agreement, our company will further increase our industrial layout and resource investment in Jimei District, continuously improve our business scale, research and development capabilities, and regional economic contributions, and strive to create a benchmark for growth oriented enterprises with industry influence.

        As a comprehensive pharmaceutical enterprise integrating pharmaceutical research and development, sales, distribution, and services, our company has long been deeply engaged in the field of biomedicine, continuously improving the industrial chain layout around innovative research and development, industrial transformation, and market expansion. Our business covers multiple sectors including global drug introduction, omni channel marketing, supply chain management, professional financial and tax services, pharmaceutical research and development, and commercial distribution. We have established a comprehensive sales management system and abundant industry resources, and our core products have strong competitive advantages in segmented markets.

Accurate benchmarking to solidify the foundation for identifying growth oriented enterprises

        In recent years, Xiamen City and Jimei District have continuously optimized the policy environment for headquarters economy and biopharmaceutical industry. According to the relevant policies of the city and district on promoting the high-quality development of headquarters economy and industry, growth oriented enterprises need to meet corresponding standards in terms of operating income, local economic contribution, research and development investment, and comprehensive benefits.

        In this cooperation, our company will actively benchmark the recognition requirements for growth oriented enterprises at the city and district levels

        Revenue target: During the agreement period, strive to achieve steady growth in business scale, with an expected revenue of over one billion yuan in the next five years;

        Local economic contribution target: The annual district level local economic contribution is expected to reach over 5 million yuan and continue to increase, meeting the recognition threshold for growth enterprises at the city and district levels;

        R&D investment and comprehensive benefits: Continuously increase R&D investment, rely on the advantages of internal resource sharing within the group, and improve the comprehensive benefits of the enterprise (including indicators such as fixed asset depreciation, wages and salaries, corporate profits, R&D investment, etc.).

Collaboration between government and enterprises to jointly build a highland for the biopharmaceutical industry

        This signing is another important achievement of Jimei District's continuous optimization of the business environment and promotion of the agglomeration and development of headquarters economy and biopharmaceutical industry. In recent years, Jimei District has continuously improved its industrial support policies around key industries such as biomedicine and high-end manufacturing, continuously attracting technology-based enterprises with growth potential to land and develop, and continuously enhancing the industrial agglomeration effect.

        Our company stated that the good industrial ecology, comprehensive policy support system, and efficient government services in Xiamen and Jimei District provide solid guarantees for the long-term development of enterprises. In the future, our company will continue to increase investment in research and development and industry, actively apply for the recognition of growth enterprises at the city and district levels, promote high-quality development of enterprises, and help upgrade the regional biopharmaceutical industry chain.

        The relevant person in charge of the Investment Promotion Bureau in Jimei District stated that they will continue to provide good service guarantees for enterprises, assist enterprises in connecting policy applications, talent introduction and other resources, support enterprises to grow and strengthen, promote the coordinated development of government and enterprises, and achieve mutual benefit and win-win results.

        Looking ahead, both parties will take this signing as an opportunity to further deepen cooperation, jointly promote innovative development of the biopharmaceutical industry, and inject new momentum into the high-quality economic development of Xiamen.